{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:47:51Z","timestamp":1787237271578,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>The presence of antibodies to donor-specific HLAs is a well-known risk factor associated with heart transplantation (HTx) outcomes. Recently, non-HLA antibodies were reported to be associated with HTx outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We evaluated the association between the presence of non-HLA antibodies with early (\u22641 y) and long-term graft failure in 192 patients undergoing HTx in 4 large transplant centers in Korea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Antibodies to vimentin (AVA) and type II collagen (ACA) were associated with a lower rate of 1-y graft survival (78.6% versus 92.6%, log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.006 for AVA\n                      <jats:sup>+<\/jats:sup>\n                      ; 72.2% versus 91.1%, log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.015 for ACA\n                      <jats:sup>+<\/jats:sup>\n                      ). AVA\n                      <jats:sup>+<\/jats:sup>\n                      stratified 1-y graft survival in patients with donor-specific antibodies (DSAs\n                      <jats:sup>+<\/jats:sup>\n                      ; 45.5% versus 94.1%, log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.002). AVA\n                      <jats:sup>+<\/jats:sup>\n                      also improved the prediction models based on conventional risk factors derived from Cox regression analysis (integrated discrimination improvement, 9%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001; net reclassification index, 24%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.047). Compared with AVA\n                      <jats:sup>\u2013<\/jats:sup>\n                      \/ACA\n                      <jats:sup>\u2013<\/jats:sup>\n                      patients, AVA\n                      <jats:sup>+<\/jats:sup>\n                      \/ACA\n                      <jats:sup>+<\/jats:sup>\n                      patients had poor graft survival both in the early and late periods (all log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>In conclusion, the presence of non-HLA antibodies to vimentin and type II collagen was associated with poor graft outcomes in patients undergoing HTx. These findings highlight the need to consider non-HLA antibodies in assessing transplant recipients and tailoring immune modulation strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005368","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T20:40:24Z","timestamp":1743108024000},"page":"1449-1457","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Utility of Non-HLA Autoantibodies in Predicting Graft Survival After Heart Transplantation"],"prefix":"10.1097","volume":"109","author":[{"given":"Gyu Chul","family":"Oh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."},{"name":"Catholic Research Institute for Intractable Cardiovascular Disease (CRID), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Chan","family":"Youn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."},{"name":"Catholic Research Institute for Intractable Cardiovascular Disease (CRID), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jai","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea."},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeehoon","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Seok","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Oh","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ho","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewon","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Min","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Joong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea."},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"R1-20251023","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2021.07.021","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report\u20142021; focus on recipient characteristics.","volume":"40","author":"Chambers","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R2-20251023","first-page":"157","article-title":"HLA typing and its influence on organ transplantation.","volume":"333","author":"Sheldon","year":"2006","journal-title":"Methods Mol Biol"},{"key":"R3-20251023","first-page":"434","article-title":"Impact of non-human leukocyte antigen-specific antibodies in kidney and heart transplantation.","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol"},{"key":"R4-20251023","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.3389\/ti.2022.10099","article-title":"Clinical significances of anti-collagen type I and type III antibodies in antibody-mediated rejection.","volume":"35","author":"Park","year":"2022","journal-title":"Transpl Int"},{"key":"R5-20251023","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/icvts\/ivv344","article-title":"The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.","volume":"22","author":"Urban","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R6-20251023","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation.","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation"},{"key":"R7-20251023","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4070\/kcj.2016.0403","article-title":"Initial report of the Korean Organ Transplant Registry (KOTRY): heart transplantation.","volume":"47","author":"Lee","year":"2017","journal-title":"Korean Circ J"},{"key":"R8-20251023","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4070\/kcj.2018.0392","article-title":"The Korean Organ Transplant Registry (KOTRY): second official adult heart transplant report.","volume":"49","author":"Kim","year":"2019","journal-title":"Korean Circ J"},{"key":"R9-20251023"},{"key":"R10-20251023"},{"key":"R11-20251023"},{"key":"R12-20251023"},{"key":"R13-20251023"},{"key":"R14-20251023","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection.","volume":"357","author":"Zou","year":"2007","journal-title":"N Engl J Med"},{"key":"R15-20251023","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1600-6143.2007.01838.x","article-title":"The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection.","volume":"7","author":"Su\u00e1rez-Alvarez","year":"2007","journal-title":"Am J Transplant"},{"key":"R16-20251023","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"key":"R17-20251023","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI38339","article-title":"Introducing intermediate filaments: from discovery to disease.","volume":"119","author":"Eriksson","year":"2009","journal-title":"J Clin Invest"},{"key":"R18-20251023","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/bies.10140","article-title":"Beyond structure: do intermediate filaments modulate cell signalling?","volume":"24","author":"Paramio","year":"2002","journal-title":"Bioessays"},{"key":"R19-20251023","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/eji.200838884","article-title":"Leukocyte transmigration is modulated by chemokine-mediated PI3K\u03b3-dependent phosphorylation of vimentin.","volume":"39","author":"Barberis","year":"2009","journal-title":"Eur J Immunol"},{"key":"R20-20251023","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.humimm.2019.03.017","article-title":"Anti-vimentin antibodies in transplant and disease.","volume":"80","author":"Divanyan","year":"2019","journal-title":"Hum Immunol"},{"key":"R21-20251023","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.biopha.2006.09.002","article-title":"Autoantibodies in rheumatoid arthritis: a review.","volume":"60","author":"Mewar","year":"2006","journal-title":"Biomed Pharmaco"},{"key":"R22-20251023","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/117727190600100006","article-title":"Identification of a specific vimentin isoform that induces an antibody response in pancreatic cancer.","volume":"1","author":"Hong","year":"2006","journal-title":"Biomark Insights"},{"key":"R23-20251023","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00007890-200104150-00011","article-title":"Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.","volume":"71","author":"Jurcevic","year":"2001","journal-title":"Transplantation"},{"key":"R24-20251023","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.healun.2010.05.025","article-title":"Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.","volume":"29","author":"Nath","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R25-20251023","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1111\/ajt.15871","article-title":"Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantation.","volume":"20","author":"See","year":"2020","journal-title":"Am J Transplant"},{"key":"R26-20251023","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/ctr.12567","article-title":"Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population.","volume":"29","author":"Young","year":"2015","journal-title":"Clin Transplant"},{"key":"R27-20251023","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/ajt.13422","article-title":"Multicenter analysis of immune biomarkers and heart transplant outcomes: Results of the clinical trials in organ transplantation-05 Study.","volume":"16","author":"Starling","year":"2016","journal-title":"Am J Transplant"},{"key":"R28-20251023","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2353\/ajpath.2007.060728","article-title":"Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.","volume":"170","author":"Mahesh","year":"2007","journal-title":"Am J Pathol"},{"key":"R29-20251023","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/01.TP.0000129068.03900.25","article-title":"Detection of vimentin-specific autoreactive CD8+ T cells in cardic transplant patients.","volume":"77","author":"Barber","year":"2004","journal-title":"Transplantation"},{"key":"R30-20251023","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1053-2498(01)00335-7","article-title":"Mycophenolate mofetil decreases antibody production after cardiac transplantation.","volume":"21","author":"Rose","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R31-20251023","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41413-019-0046-y","article-title":"Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin beta1-SMAD1 interaction.","volume":"7","author":"Lian","year":"2019","journal-title":"Bone Res"},{"key":"R32-20251023","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation.","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:00:28Z","timestamp":1761217228000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005368","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}